Stereotaxis Achieves CE Mark in Europe and Submits 510(k) in the US for Next Generation Robotic System GenesisXGlobeNewsWire • 08/12/24
Stereotaxis to Report Second Quarter 2024 Financial Results on August 12, 2024GlobeNewsWire • 07/22/24
Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart TreatmentGlobeNewsWire • 05/29/24
Stereotaxis Receives CE Mark Recertification Under EU's MDR Regulatory FrameworkGlobeNewsWire • 05/24/24
First Heart Rhythm Patients in Southern Italy Treated with Advanced Robotic TechnologyGlobeNewsWire • 05/22/24
Stereotaxis Invited by Africa Heart Rhythm Association to Present its Innovative Robotic Solution to Expand High-Quality Therapy in Underserved Regions of AfricaGlobeNewsWire • 05/15/24
Stereotaxis Announces Definitive Agreement to Acquire Access Point TechnologiesGlobeNewsWire • 05/13/24